US 12,173,013 B2
Synthetic processes and synthetic intermediates
Sanjeevani Ghone, Monmouth Junction, NJ (US); Fu-An Kang, Monmouth Junction, NJ (US); Nareshkumar Jain, Monmouth Junction, NJ (US); Ajit K. Parhi, Monmouth Junction, NJ (US); Ravi Ponnaiah, Hyderabad (IN); Anil Kumar Soni, Hyderabad (IN); Siva Rami Reddy Athunuri, Hyderabad (IN); Thrisulapani Korrakuti, Hyderabad (IN); and Pullarao Seelam, Hyderabad (IN)
Assigned to Taxis Pharmaceuticals, Inc., Monmouth Junction, NJ (US)
Filed by TAXIS PHARMACEUTICALS, INC., Monmouth Junction, NJ (US)
Filed on Jan. 31, 2023, as Appl. No. 18/104,013.
Application 18/104,013 is a continuation of application No. 16/997,716, filed on Aug. 19, 2020, abandoned.
Application 16/997,716 is a continuation of application No. 16/498,870, granted, now 10,774,093, issued on Sep. 15, 2020, previously published as PCT/US2018/025502, filed on Mar. 30, 2018.
Claims priority of application No. 201741011533 (IN), filed on Mar. 30, 2017.
Prior Publication US 2023/0257397 A1, Aug. 17, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. C07D 513/04 (2006.01); B01J 23/44 (2006.01)
CPC C07D 513/04 (2013.01) [B01J 23/44 (2013.01)] 16 Claims
 
1. A process for preparing TXA709:

OG Complex Work Unit Chemistry
comprising converting an amide of formula 9:

OG Complex Work Unit Chemistry
to TXA709 on a commercial scale.